Alkem Laboratories Receives EU GMP Certificate for Baddi Facility
Filing Summary
Alkem Laboratories Ltd has received a ‘Certificate of GMP Compliance of a Manufacturer’ for its manufacturing facility located in Baddi, India. The certificate was issued by the Department of Pharmacy (Human Medicines) – Germany, following an inspection conducted from November 4 to November 10, 2025. This certification is valid for three years from the date of inspection. The company disclosed this information in compliance with Regulation 30 of the SEBI LODR Regulations. The disclosure will be available on Alkem’s website as per regulatory requirements.
Alkem Laboratories Ltd has announced the receipt of a ‘Certificate of GMP Compliance of a Manufacturer’ for its manufacturing facility located at Baddi, India. This certification was granted by the Department of Pharmacy (Human Medicines) – Germany following an inspection conducted from November 4 to November 10, 2025.
The certificate is valid for a period of three years from the date of inspection. This information was disclosed in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. The company had previously informed about the EU GMP inspection by the German Health Authority at the Baddi facility on November 10, 2025.
A copy of this disclosure will be made available on the company’s website in compliance with Regulation 30(8) of the SEBI LODR Regulations. This ensures transparency and accessibility of information for stakeholders and investors.
Alkem Laboratories Ltd is engaged in the development, manufacture, and sale of pharmaceutical products. The company focuses on providing a wide range of generic and branded medicines across various therapeutic areas. Alkem is committed to maintaining high standards of quality and compliance in its manufacturing processes.